The synthesis of a DOPA analogue, 1-amino-2-(3, 4-dihydroxyphenyl)-ethylphosphonic acid and distribution studies in mice bearing the Harding-Passey melanoma.
D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D001487:Basidiomycota / Q000201:enzymology; D004156:Catechol Oxidase / Q000378:metabolism; D002855:Chromatography, Thin Layer; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000633:toxicity; D005123:Eye / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008545:Melanoma / Q000378:metabolism*; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism; D063065:Organophosphonates / Q000138:chemical synthesis / Q000378:metabolism / Q000633:toxicity; D013997:Time Factors; D014316:Tritium
D063065:Organophosphonates; D014316:Tritium; D004295:Dihydroxyphenylalanine; D004156:Catechol Oxidase